These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24126794)

  • 1. Impact of folate supplementation on the efficacy of sulfadoxine/pyrimethamine in preventing malaria in pregnancy: the potential of 5-methyl-tetrahydrofolate.
    Nzila A; Okombo J; Molloy AM
    J Antimicrob Chemother; 2014 Feb; 69(2):323-30. PubMed ID: 24126794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment.
    Peters PJ; Thigpen MC; Parise ME; Newman RD
    Drug Saf; 2007; 30(6):481-501. PubMed ID: 17536875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of intermittent preventive treatment of malaria against group B Streptococcus colonization in pregnant women: a nested analysis of a randomized controlled clinical trial of sulfadoxine/pyrimethamine versus mefloquine.
    Capan-Melser M; Mombo Ngoma G; Akerey-Diop D; Basra A; Würbel H; Groger M; Mackanga JR; Zoleko-Manego R; Schipulle U; Schwing J; Lötsch F; Rehman K; Matsiegui PB; Agnandji ST; Adegnika AA; Bélard S; González R; Kremsner PG; Menendez C; Ramharter M
    J Antimicrob Chemother; 2015; 70(6):1898-902. PubMed ID: 25722300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scaling-up the use of sulfadoxine-pyrimethamine for the preventive treatment of malaria in pregnancy: results and lessons on scalability, costs and programme impact from three local government areas in Sokoto State, Nigeria.
    Orobaton N; Austin AM; Abegunde D; Ibrahim M; Mohammed Z; Abdul-Azeez J; Ganiyu H; Nanbol Z; Fapohunda B; Beal K
    Malar J; 2016 Nov; 15(1):533. PubMed ID: 27814763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The challenge of using intermittent preventive therapy with sulfadoxine/pyrimethamine among pregnant women in Uganda.
    Wanzira H; Katamba H; Okullo AE; Rubahika D
    Malar J; 2016 Aug; 15(1):401. PubMed ID: 27506609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-dose versus monthly intermittent preventive treatment of malaria with sulfadoxine-pyrimethamine in HIV-seropositive pregnant Zambian women.
    Hamer DH; Mwanakasale V; Macleod WB; Chalwe V; Mukwamataba D; Champo D; Mwananyanda L; Chilengi R; Mubikayi L; Mulele CK; Mulenga M; Thea DM; Gill CJ
    J Infect Dis; 2007 Dec; 196(11):1585-94. PubMed ID: 18008241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial of 2-dose versus monthly sulfadoxine-pyrimethamine intermittent preventive treatment for malaria in HIV-positive and HIV-negative pregnant women in Malawi.
    Filler SJ; Kazembe P; Thigpen M; Macheso A; Parise ME; Newman RD; Steketee RW; Hamel M
    J Infect Dis; 2006 Aug; 194(3):286-93. PubMed ID: 16826475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High folate levels are not associated with increased malaria risk but with reduced anaemia rates in the context of high-dosed folate supplements and intermittent preventive treatment against malaria in pregnancy with sulphadoxine-pyrimethamine in Benin.
    Moya-Alvarez V; Ouédraogo S; Accrombessi M; Cot M
    Trop Med Int Health; 2018 Jun; 23(6):582-588. PubMed ID: 29683544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma folate level and high-dose folate supplementation predict sulfadoxine-pyrimethamine treatment failure in pregnant women in Western kenya who have uncomplicated malaria.
    van Eijk AM; Ouma PO; Williamson J; Ter Kuile FO; Parise M; Otieno K; Hamel MJ; Ayisi JG; Kariuki S; Kager PA; Slutsker L
    J Infect Dis; 2008 Nov; 198(10):1550-3. PubMed ID: 18831691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of inhibition of the anti-malarial action of sulfadoxine-pyrimethamine by folic acid supplementation when used for intermittent preventive treatment in Gambian primigravidae.
    Mbaye A; Richardson K; Balajo B; Dunyo S; Shulman C; Milligan P; Greenwood B; Walraven G
    Am J Trop Med Hyg; 2006 Jun; 74(6):960-4. PubMed ID: 16760504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of intermittent preventive treatment with sulfadoxine-pyrimethamine for preventing malaria in pregnant women.
    Leke RG; Taylor DW
    Clin Infect Dis; 2011 Aug; 53(3):231-3. PubMed ID: 21765071
    [No Abstract]   [Full Text] [Related]  

  • 12. Superiority of 3 over 2 doses of intermittent preventive treatment with sulfadoxine-pyrimethamine for the prevention of malaria during pregnancy in mali: a randomized controlled trial.
    Diakite OS; Kayentao K; Traoré BT; Djimde A; Traoré B; Diallo M; Ongoiba A; Doumtabé D; Doumbo S; Traoré MS; Dara A; Guindo O; Karim DM; Coulibaly S; Bougoudogo F; Ter Kuile FO; Danis M; Doumbo OK
    Clin Infect Dis; 2011 Aug; 53(3):215-23. PubMed ID: 21765069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inferiority of single-dose sulfadoxine-pyrimethamine intermittent preventive therapy for malaria during pregnancy among HIV-positive Zambian women.
    Gill CJ; Macleod WB; Mwanakasale V; Chalwe V; Mwananyanda L; Champo D; Mukwamataba D; Chilengi R; Thea DM; Hamer DH
    J Infect Dis; 2007 Dec; 196(11):1577-84. PubMed ID: 18008240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malaria prevention in pregnancy, birthweight, and neonatal mortality: a meta-analysis of 32 national cross-sectional datasets in Africa.
    Eisele TP; Larsen DA; Anglewicz PA; Keating J; Yukich J; Bennett A; Hutchinson P; Steketee RW
    Lancet Infect Dis; 2012 Dec; 12(12):942-9. PubMed ID: 22995852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of intermittent preventive treatment with sulfadoxine-pyrimethamine on the prevalence of malaria parasitaemia in pregnancy.
    Umeh UA; Obi SN; Onah HE; Ugwu EO; Ajah LO; Umeh CR; Okafor II
    Trop Doct; 2012 Jul; 42(3):133-5. PubMed ID: 22399105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a community-based delivery of intermittent preventive treatment of malaria in pregnancy on treatment seeking for malaria at health units in Uganda.
    Mbonye AK; Schultz Hansen K; Bygbjerg IC; Magnussen P
    Public Health; 2008 May; 122(5):516-25. PubMed ID: 18358506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of two antifolate prophylactic strategies against malaria in HIV-positive pregnant women in Bangui, Central African Republic: study protocol for a randomized controlled trial (MACOMBA).
    Manirakiza A; Sepou A; Serdouma E; Gondje S; Bata GG; Moussa S; Boulay A; Moyen JM; Sakanga O; Le-Fouler L; Kazanji M; Vray M
    Trials; 2013 Aug; 14():255. PubMed ID: 23945130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A community effectiveness trial of strategies promoting intermittent preventive treatment with sulphadoxine-pyrimethamine in pregnant women in rural Burkina Faso.
    Gies S; Coulibaly SO; Ouattara FT; Ky C; Brabin BJ; D'Alessandro U
    Malar J; 2008 Sep; 7():180. PubMed ID: 18801158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malaria prevention during pregnancy: assessing the disease burden one year after implementing a program of intermittent preventive treatment in Koupela District, Burkina Faso.
    Sirima SB; Cotte AH; Konaté A; Moran AC; Asamoa K; Bougouma EC; Diarra A; Ouédraogo A; Parise ME; Newman RD
    Am J Trop Med Hyg; 2006 Aug; 75(2):205-11. PubMed ID: 16896120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of two versus three or more doses of intermittent preventive treatment for malaria during pregnancy in sub-Saharan Africa: a modelling study of meta-analysis and cost data.
    Fernandes S; Sicuri E; Kayentao K; van Eijk AM; Hill J; Webster J; Were V; Akazili J; Madanitsa M; ter Kuile FO; Hanson K
    Lancet Glob Health; 2015 Mar; 3(3):e143-53. PubMed ID: 25701992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.